ATE484591T1 - Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression - Google Patents

Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression

Info

Publication number
ATE484591T1
ATE484591T1 AT04791263T AT04791263T ATE484591T1 AT E484591 T1 ATE484591 T1 AT E484591T1 AT 04791263 T AT04791263 T AT 04791263T AT 04791263 T AT04791263 T AT 04791263T AT E484591 T1 ATE484591 T1 AT E484591T1
Authority
AT
Austria
Prior art keywords
dna sequence
protein expression
chromatin insulator
minimal dna
sequence acting
Prior art date
Application number
AT04791263T
Other languages
English (en)
Inventor
Philippe Chatellard
Markus Imhof
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE484591T1 publication Critical patent/ATE484591T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04791263T 2003-10-21 2004-10-20 Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression ATE484591T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103890 2003-10-21
PCT/EP2004/052591 WO2005040384A1 (en) 2003-10-21 2004-10-20 Minimal dna sequence acting as a chromatin insulator and its use in protein expression

Publications (1)

Publication Number Publication Date
ATE484591T1 true ATE484591T1 (de) 2010-10-15

Family

ID=34486337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791263T ATE484591T1 (de) 2003-10-21 2004-10-20 Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression

Country Status (17)

Country Link
US (1) US8133699B2 (de)
EP (1) EP1675956B1 (de)
JP (1) JP4745972B2 (de)
AT (1) ATE484591T1 (de)
AU (1) AU2004284243B2 (de)
CA (1) CA2541523A1 (de)
CY (1) CY1110868T1 (de)
DE (1) DE602004029598D1 (de)
DK (1) DK1675956T3 (de)
ES (1) ES2354160T3 (de)
HR (1) HRP20100560T1 (de)
IL (1) IL175021A (de)
NO (1) NO338767B1 (de)
PL (1) PL1675956T3 (de)
PT (1) PT1675956E (de)
SI (1) SI1675956T1 (de)
WO (1) WO2005040384A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330201T3 (es) 2001-01-26 2009-12-07 Selexis S.A. Regiones de union a la matriz y metodos para el uso de las mismas.
PT1601776E (pt) 2003-03-11 2008-09-17 Serono Lab Vectores de expressão que compreendem o promotor ie2 do mcmv
DK1622939T3 (da) * 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
EP1959011B1 (de) 2003-10-24 2012-03-28 Selexis S.A. Gentransfer und Expression mit hoher Effizienz in Säugerzellen mittels eines Mehrfachtransfektionsverfahrens von Matrixbindungsbereichsequenzen
AU2004291341B2 (en) * 2003-11-05 2010-08-05 Ares Trading S.A. Process for the purification of IL-18 binding protein
PL1720979T3 (pl) * 2004-03-01 2008-03-31 Ares Trading Sa Zastosowanie podłoża pozbawionego surowicy do hodowli komórkowej do wytwarzania IL-18BP w komórkach ssaków
DE602005009827D1 (de) 2004-06-29 2008-10-30 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
EP2267024B1 (de) 2005-06-03 2012-05-09 Ares Trading S.A. Herstellung von rekombinantem Il-18 bindendem Protein
SI1891088T1 (sl) * 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
EP1760092A1 (de) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System für Screening von Zellen mit hoher Expression von einem interessierenden Protein
FR2919616A1 (fr) * 2007-08-02 2009-02-06 Ecole Norm Superieure Lyon Polynucleotides insulateurs derives de l'element d4z4 et leurs utilisations en transgenese
CN103620034B (zh) 2011-04-13 2016-12-14 加拿大国家研究委员会 具有来自IFNα2的SAR元件的表达系统
US20140342432A1 (en) * 2011-12-21 2014-11-20 Danisco Us Inc. Fungal Gene Expression Using Insulator DNA Sequences
EP3483178B1 (de) 2012-07-31 2020-10-28 AgeX Therapeutics, Inc. Verfahren zur herstellung hla-g-modifiziertern zellen
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
US11246896B2 (en) 2015-10-28 2022-02-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Tumor-specific adenovirus vectors and therapeutic uses
KR102766526B1 (ko) 2015-10-28 2025-02-13 상가모 테라퓨틱스, 인코포레이티드 간-특이적 작제물인, 인자 viii 발현 카세트 및 이의 사용 방법
JP7308034B2 (ja) 2016-07-01 2023-07-13 リゾルブ セラピューティクス， エルエルシー 最適化二重ヌクレアーゼ融合物および方法
CN106754817B (zh) * 2016-11-03 2021-02-05 山西省生物研究院有限公司 一种重组自分泌运动因子的表达方法
WO2019040674A1 (en) 2017-08-22 2019-02-28 Sanabio, Llc SOLUBLE INTERFERON RECEPTORS AND USES THEREOF
CA3100946A1 (en) 2018-05-22 2019-11-28 The Brigham And Women's Hospital, Inc. Gene therapy for alzheimer's disease
JP7684212B2 (ja) 2018-08-03 2025-05-27 サンガモ セラピューティクス， インコーポレイテッド 第ｖｉｉｉ因子の発現による改善された臨床パラメーター
EP3976637A4 (de) 2019-05-24 2023-07-12 The Brigham and Women's Hospital, Inc. Gentherapie für morbus alzheimer
KR20220108096A (ko) * 2019-11-29 2022-08-02 파로스 바이오, 인코포레이티드 신경퇴행성 질환에 대한 유전자 요법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
US6432700B1 (en) * 1997-03-03 2002-08-13 Cell Genesys, Inc. Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
US6194152B1 (en) * 1997-08-20 2001-02-27 Dendreon Corporation Prostate tumor polynucleotide compositions and methods of detection thereof
US6395549B1 (en) * 1998-10-22 2002-05-28 Medical College Of Georgia Research Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
WO2001002553A2 (en) * 1999-06-30 2001-01-11 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression
PT1601776E (pt) 2003-03-11 2008-09-17 Serono Lab Vectores de expressão que compreendem o promotor ie2 do mcmv
DK1622939T3 (da) 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
AU2004291341B2 (en) * 2003-11-05 2010-08-05 Ares Trading S.A. Process for the purification of IL-18 binding protein
PL1720979T3 (pl) 2004-03-01 2008-03-31 Ares Trading Sa Zastosowanie podłoża pozbawionego surowicy do hodowli komórkowej do wytwarzania IL-18BP w komórkach ssaków
DE602005009827D1 (de) * 2004-06-29 2008-10-30 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
EP2267024B1 (de) 2005-06-03 2012-05-09 Ares Trading S.A. Herstellung von rekombinantem Il-18 bindendem Protein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina

Also Published As

Publication number Publication date
US8133699B2 (en) 2012-03-13
IL175021A (en) 2011-07-31
PL1675956T3 (pl) 2011-06-30
NO338767B1 (no) 2016-10-17
AU2004284243A1 (en) 2005-05-06
DE602004029598D1 (de) 2010-11-25
CY1110868T1 (el) 2015-06-10
PT1675956E (pt) 2010-11-04
CA2541523A1 (en) 2005-05-06
ES2354160T3 (es) 2011-03-10
US20070134761A1 (en) 2007-06-14
IL175021A0 (en) 2006-08-20
JP4745972B2 (ja) 2011-08-10
HRP20100560T1 (hr) 2010-11-30
NO20062315L (no) 2006-07-18
DK1675956T3 (da) 2010-11-22
SI1675956T1 (sl) 2010-12-31
EP1675956B1 (de) 2010-10-13
EP1675956A1 (de) 2006-07-05
JP2007508833A (ja) 2007-04-12
AU2004284243B2 (en) 2010-11-04
WO2005040384A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
ATE484591T1 (de) Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
ATE342917T1 (de) Antimikrobielle polypeptide aus pseudoplectania nigrella
ATE512980T1 (de) Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE492633T1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
AR047347A1 (es) Miembros de la familia cry9 de bacillus
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE60206885D1 (de) Agarase und gen dafür
ATE384787T1 (de) Tripeptidyl-aminopeptidase
ATE362544T1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
ATE532861T1 (de) Expressionsvektor
DK0724637T4 (da) Kortikotropinfrigørende faktor2-receptorer
DE60319369D1 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
ATE442445T1 (de) Rhamnose-induzierbares expressionssystem
ATE447013T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid
DE60330116D1 (de) Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung
ATE327987T1 (de) Methylthiophencarboxanilide
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
ATE452980T1 (de) Beim frühen blütenstand bevorzugte regulationselemente und verwendungen davon
ATE276372T1 (de) Pichia methanolica glyceraldehyd-3-phosphat- dehydrogenase-1-promoter und -terminator

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1675956

Country of ref document: EP